Abstract
Certain adult T-cell lymphoproliferative disorders are associated with human T-cell leukaemia virus (HTLV), a unique human type C retrovirus1,2. (The strains of HTLV used in these studies belong to the subgroup HTLV-I.) HTLV is not an endogenous agent in man, but rather is an acquired virus with T-cell tropism3,4. Neoplastic cells from patients infected with HTLV generally express receptors for T-cell growth factor (TCGF) (interleukin-2)5,6, and do not require prior activation with antigens or lectins to undergo TCGF-induced proliferation. Furthermore, neoplastic T-cell lines originating from such patients may constitutively produce TCGF, TCGF receptors and HTLV virions3. HTLV is transmissible from cell to cell, and the infection of human T cells in vitro is associated with the expression of TCGF receptors6, which can be identified by the monoclonal antibody termed anti-Tac7–9. In our experience to date, T-cell populations that produce HTLV without exception also express epitopes found on TCGF receptors. Recognition of an association between HTLV virions and the Tac antigen would have clinical and theoretical implications. We now present evidence that during the replication or release of HTLV, the virion becomes preferentially associated with the Tac antigen.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Poiesz, B. J., Ruscetti, F. W., Reitz, M. S., Kalyanaraman, V. S. & Gallo, R. C. Nature 294, 268–271 (1981).
Gallo, R. C. & Reitz, M. S. J. natn. Cancer Inst. 69, 1209–1212 (1982).
Poiesz, B. J. et al. Proc. natn. Acad. Sci. U.S.A. 77, 7415–7419 (1980).
Gallo, R. C. et al. Proc. natn. Acad. Sci. U.S.A. 79, 5680–5683 (1982).
Morgan, D. A., Ruscetti, F. W. & Gallo, R. C. Science 193, 1007–1008 (1976).
Gallo, R. C. et al. UCLA Symp. molec. cell. Biol. New Ser. Vol. 1 (eds Marchesi, V. T. & Gallo, R. C.) 231–246 (Liss, New York, 1982).
Uchiyama, T., Broder, S. & Waldmann, T. A. J. Immun. 126, 1393–1397 (1981).
Leonard, W. J. et al. Nature 300, 267–269 (1982).
Leonard, W. J., Depper, J. M., Robb, R. J., Waldmann, T. A. & Greene, W. C. Proc. natn. Acad. Sci. U.S.A. (in the press).
Popovic, M. et al. Science 219, 856–859 (1983).
Robert-Guroff, M., Ruscetti, F. W., Posner, L. E., Poiesz, B. J. & Gallo, R. C. J. exp. Med. 154, 1957–1964 (1981).
Grant, J. P., Bigner, D. D., Fischinger, P. J. & Bolognesi, D. P. Proc. natn. Acad. Sci. U.S.A. 71, 5037–5041 (1974).
Witte, O. N. & Weissmann, I. L. Virology 61, 575–587 (1974).
Witte, O. N. & Weissman, I. L. Virology 69, 464–473 (1976).
Witte, O. N., Tsukamoto-Adey, A. & Weissman, I. L. Virology 76, 539–553 (1977).
Schrader, J. W., Cunningham, B. A. & Edelman, G. M. Proc. natn. Acad. Sci. U.S.A. 72, 5066–5070 (1975).
Bubbers, J. E. & Lilly, F. Nature 266, 458–459 (1977).
Yoshiki, T., Mellors, R. C., Hardy, W. D. & Fleissner, E. J. exp. Med. 139, 925–942 (1974).
Kurth, R. Nature 256, 613–614 (1975).
Lee, T. H., Essex, M., deNoronha, F. & Azocar, J. Cancer Res. 42, 3995–3999 (1982).
Scheinberg, D. A. & Strand, M. Molec. cell Biol. 1, 144–152 (1981).
Hay, A. J. Virology 60, 398–418 (1974).
Atkinson, P. H., Moyer, S. A. & Summers, D. F. J. molec. Biol. 102, 613–631 (1976).
Leamnson, R. N., Shander, M. H. M. & Halpern, M. S. Virology 76, 437–439 (1977).
Bolognesi, D. P., Montelaro, R. C., Frank, H. & Schäfer, W. Science 199, 183–186 (1978).
Weiss, R. A. Cell Membrane Receptors for Viruses, Antigens and Antibodies, Polypeptide Hormones and Small Molecules (eds Beers, R. F. & Bassett, E. G.) 237–251 (Raven, New York, 1976).
Weiss, R. in RNA Tumor Viruses (eds Weiss, R., Teich, N., Varmus, H. & Coffin, J.) 209–260 (Cold Spring Harbor Laboratory, New York, 1982).
Delarco, J. & Todaro, G. J. Cell 8, 365–371 (1976).
Baird, S., Raschke, W. & Weissman, I. L. Int. J. Cancer 19, 403–413 (1977).
Kalyanaraman, V. S., Sarngadharan, M. G. & Gallo, R. C. J. Virol. 28, 686–696 (1978).
Miyamoto, K. & Gilden, R. V. J. Virol. 7, 395–406 (1971).
Cogniaux, J., Olislager, R., Sprecher-Goldberger, S. & Thiry, L. J. Virol. 43, 664–672 (1982).
Robb, R. J., Kutny, R. M. & Chowdhry, V. Proc. natn. Acad. Sci. U.S.A. (in the press).
Toplin, I. & Sottong, P. Appl. Microbiol. 23, 1010–1014 (1972).
Douillard, J. Y., Hoffman, T. & Herberman, R. B. J. immun. Meth. 39, 309–316 (1980).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lando, Z., Sarin, P., Megson, M. et al. Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor. Nature 305, 733–736 (1983). https://doi.org/10.1038/305733a0
Received:
Accepted:
Issue date:
DOI: https://doi.org/10.1038/305733a0
This article is cited by
-
T-Cell Control by Human T-Cell Leukemia/Lymphoma Virus Type 1
International Journal of Hematology (2003)
-
T-helper phenotype chronic lymphocytic leukemia (Thp-CLL): Characterization of an Italian case with particular biological findings
Blut (1987)
-
Isolation of HTLV-transformed B-lymphocyte clone from a patient with HTLV-associated adult T-cell leukaemia
Nature (1984)